Another receptor frequently overexpressed in triple-negative breast cancers (TNBCs), a subgroup associated with particularly poor treatment response and outcomes, is the epidermal growth factor receptor (EGFR) [4–6]. Here, EGFR is linked to triple-negative breast carcinoma.